Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Clinical Pharmacology and Therapeutics|May 25, 2021
Japan's Special Approval for Emergency System During the COVID-19 PandemicHideki MaedaFrontiers in Medicine|January 31, 2022
The Current Status and Future Direction of Clinical Research in Japan From a Regulatory PerspectiveHideki MaedaFrontiers in Medicine|August 26, 2021
Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in JapanHideki MaedaJournal of Clinical Pharmacology|January 7, 2015
Regulatory review time for approval of oncology drugs in Japan between 2001 and 2014. Considerations of changes, factors that affect review time, and difference with the United StatesHideki Maeda, Tatsuo KurokawaGan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2014
[Enzalutamide-a novel androgen receptor inhibitor that provides treatment options for patients with castration-resistant prostate cancer]Hideki Maeda, Atsushi SaitoClinical and Translational Science|May 6, 2024
Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic reviewKatsutoshi Hiramatsu, Hideki MaedaCurrent Oncology (Toronto, Ont.)|June 25, 2026
Identifying Factors Associated with the Acquisition of Multiple Indications for Anticancer DrugsShutaro Takahashi, Hideki MaedaInvestigational New Drugs|March 12, 2014
Differences in maximum tolerated doses and approval doses of molecularly targeted oncology drug between Japan and Western countriesHideki Maeda, Tatsuo KurokawaJapanese Journal of Clinical Oncology|September 27, 2013
Involvement of anticancer drugs in the relief system for adverse drug reactions in JapanHideki Maeda, Tatsuo KurokawaFrontiers in Medical Technology|August 21, 2024
Trends in the market for drug delivery devices categorized as combination drugs and medical devices and regulatory challenges for autoinjectors in JapanMakiko Mochizuki, Hideki MaedaPageof 8